Company intelligence / Profile preview

DCVC Bio

Palo Alto, California, United Statesdcvc.com ↗

Ownership: Private
Employees: ~69
Development stage: Other

Overview

DCVC Bio is an active Silicon Valley-based venture capital firm specializing in early-stage deep tech startups within life sciences. It backs companies leveraging AI and data science to accelerate drug discovery and development across therapeutics platforms and industrial biotech. The firm has raised multiple funds—including a $400 million fund in 2024—and supports innovations spanning small molecules to cell engineering for applications in human health, agriculture, and sustainability.

Industry: Investors

Partnerships

Investment syndicates and co-investors (at the fund level)

Beyond the preview

Go deeper on DCVC Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DCVC Bio.

Explore the full profile